Considerations in using the i.v. route for drug delivery.
Akers
M J
MJ
Parenteral Products Development, Lilly Research Laboratories, Indianapolis, IN 46285.
D004340:Drug Contamination; D004342:Drug Hypersensitivity / Q000209:etiology; D004344:Drug Incompatibility; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000209:etiology; D006801:Humans; D007239:Infections / Q000209:etiology; D007275:Injections, Intravenous / Q000009:adverse effects* / Q000191:economics; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D011041:Poisoning / Q000209:etiology; D013923:Thromboembolism / Q000209:etiology
D004364:Pharmaceutical Preparations